HIV meds to remain on preferred status with Medicaid
All single-pill HIV regimens will remain on preferred status with Medicaid. This news comes after State Sen. Vincent Fort (D-Atlanta) and several LGBT rights groups called on the Georgia Department of Community Health (DCH) to reconsider a proposed move that would downgrade several HIV medications from preferred status on its Medicaid formulary. The change would have left only one single-pill daily HIV medication, Atripla, under preferred status, although patients currently taking the other once-daily regimens would have the option of being grandfathered in.
Sen. Fort sent a letter to DCH Commissioner Clyde Reese on Aug. 15 voicing his objections to the proposed change, citing several statistics on HIV/AIDS medications and saying, “I urge you to reconsider your proposal for the sake of public health. This change could prove to be disastrous and could set our state back in the fight against HIV/AIDS.”
In a conversation with Georgia Voice, Commissioner Reece’s office confirmed that the change would be reflected on DCH’s website pending an update.